Dyskeratosis congenita: Multisystemic disorder with special consideration of immunologic aspects

Clinical Pediatrics

Volumn 37, Issue 9, 1998, Pages 521-530

  Sölder, Brigitte ^a   Weiss, Michael ^b   Jäger, Andrea ^b   Belohradsky, Bernd H ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; RETINOID;

BONE MARROW TRANSPLANTATION; CELLULAR IMMUNODEFICIENCY; CLINICAL FEATURE; DYSKERATOSIS CONGENITA; HUMAN; HUMORAL IMMUNE DEFICIENCY; INFECTION; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; PANCYTOPENIA; PATHOGENESIS; PROGNOSIS; REVIEW; SKIN MANIFESTATION; X CHROMOSOME LINKED DISORDER;

EID: 0031755117     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289803700901     Document Type: Review

References (69)

1. Cole HN, Rauschkolb JE, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Dermatol Syphilol. 1930;21:71-95.
2. Engman MF. A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syphilol. 1926;13: 685-687.
3. Zinsser F. Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukoplakia oris. Ikonogr Dermatol, Kyoto. 1906:219-223.
4. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood, 4th ed. Philadelphia: W B Saunders; 1993:249-252.
5. Gutman A, Frumkin A, Adam A, et al. X-linked dyskeratosis congenita with pancytopenia. Arch Dermatol. 1978;114:1667-1671.
6. Womer R, Clark JE, Wood P, et al. Dyskeratosis congenita: two examples of this multisystem disorder. Pediatrics. 1983;71:603-609.
7. Drachtman RA, Alter BP. Dyskeratosis congenita: clinical and genetic hetrogeneity. Am J Pediatr Hematol Oncol. 1992;14:297-304.
8. De Boeck K, Degreef H, Verwilghen R, et al. Thrombocytpopenia: first symptom in a patient with dyskeratosis congenita. Prdiatrics. 1981;67:898-903.
9. Steier W, Van Voolen GA, Selmanowitz VJ. Dyskeratosis congenita: relationship to Fanconi's anemia. Blood. 1972;39:510-521.
10. Lee BW, Yap HK, Quah TC, et al. T cell immunodeficiency in dyskeratosis congenita. Arch Dis Child. 1992;67: 524-526.
11. Bundino S, Zina AM, Bernengo MG. Dyskeratosis congenita with epidermodysplasia verruciformis of Lewandowsky and Lutz. Dermatologica. 1978;156:15-23.
12. Wiedemann HP, Me Guire J, Dwyer JM, et al. Progressive immune failure in dyskeratosis congenita. Arch Intern Med. 1984;144;397-399.
13. Fudenberg HH, Goust JM, Vesole DH, Salinas CF. Active and suppressor T cells: diminution in a patient with dyskeratosis congenita and in first-degree relatives. Gerontol. 1979;25:231-237.
14. Colvin BT, Baker H, Hibhin JA, et al. Haemopoietic progenitor cells in dyskeratosis congenita. Br J Haematol. 1984;56:513-515.
15. Burkhardt D, Schirren CG, Schuffenhauer S, et al. Dyskeratosis congenita in monozygous twins. Hautarzt. 1994;45:249-255.
16. Melamed J, Rubinstein A, Kadish A, et al. Impairment of cell-mediated immunity in ectodermal dysplasia with a plastic anemia. Helv Paediatr Acta. 1978;33:169-176.
17. Schneider A, Mayer U, Gebhart E, et al. Clastogen-incluced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anaemia. Eur J Pediatr, 1988;148:37-39.
18. Russo CL, Glader BE, Israel RJ, Galasso F. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony- stimulating factor. Lancet. 1990;336: 751-752.
19. Verra F, Kouzan S, Saiag P,et al. Bronchoalveolar disease in dyskeratosis congenita. Eur Respir J. 1992;5:497-499.
20. Kawaguchi K, Sakamaki H, Onozawa Y, Koike M. Dyskeratosis congenita (Zinsser-Cole-Engman syndrome). Virch Arch A Pathol Anat Histopathol. 1990;417:247-253.
21. Sirinavin C, Trowbridge AA. Dyskeratosis congenita: clinical features and genetic aspects. J Med Genet. 1975;12: 339-354.
22. Ortega JA, Swanson VL, Landing BH, Hammond GD. Congenital dyskeratosis. Zinsser-Cole-Engman syndrome with thymic dysplasia and aplastic anemia. Am J Dis Child. 1972;124:701-704.
23. Wald C, Diner H. Dyskeratosis congenita with associated periodontal disease. Oral Surg Med Pathol. 1974;37: 736-744.
24. Dokal I, Bungey J, Williamson P, et al. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood. 1992;80:3090-3096.
25. Tchou PK, Kohn T. Dyskeratosis congenita: an autosomal dominant disorder. J Am Acad Dermatol. 1982;6:1034-1039.
26. Giannetti A, Seidenari S. Deficit of cell-mediated immunity, chromosomal alterations and defective DNA repair in a case of dyskeratosis congenita. Dermatologica. 1980;160:113-117.
27. Hanada T, Abe T, Nakazawa M, et al. Bone marrow failure in dyskeratosis congenita. Scand J Haematol. 1984;32: 496-500.
28. Haneke E, Djawari D, Keller J. Thymopoietin therapy of the susceptibility to infections in dyskeratosis congenita. Arch Dermatol Res. 1983;275: 264-265.
29. Connor JM, Teague RH. Dyskeratosis congenita. Report of a large kindred. Br J Dermatol. 1981;105:321-325.
30. Mahmoud HK, Schaefer UW, Schmidt CG, et al. Marrow transplantation for pancytopenia in dyskeratosis congenita. Blut. 1985;51:57-60.
31. Ling NS, Fenske NA, Julius RL, et al. Dyskeratosis congenita in a girl simulating chronic graft-vs-host disease. Arch Dermatol. 1985;121:1421-1428.
32. Schamfuß S, Scholz A, Peschek T, Herrmann R. Zinsser-Engman-Cole Syndrom bei 2 Brüdern. Dermatol Monatsschr. 1986;172:201-208.
33. Kehrer H, Krone W, Schindler D, et al. Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita. Clin Genet. 1992;41:129-134.
34. Arngrimsson R, Dokal I, Luzzatto L, Connor JM. Dyskeratosis congenita: three additional families show a linkage to a locus in Xq28. J Med Genet. 1993;30:618-619.
35. Connor JM, Gatherer D, Gray KC, et al. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet. 1986;72:348-351.
36. Knight SW, Vulliamy T, Forni GL, et al. Fine mapping of the dyskeratosis congenita locus in Xq28. J Med Genet. 1996;33:993-995.
37. Marsh JCW, Will AJ, Hows JM, et al. "Stem cell" origin of the hematopoietic defect in dyskeratosis congenita. Blood. 1992;79:3138-3144.
38. Juneja HS, Elder FFB, Gardner FH. Abnormality of platelet size and T- lymphocyte proliferation in an autosomal recessive form of dyskeratosis congenita. Eur J Haematol. 1987;39: 306-310.
39. Friedland M, Lutton JD, Spitzer R, Levere RD. Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. Am J Hematol. 1985;20:85-87.
40. Berthou Ch, Devergie A, D'Agay MF, et al. Late vascular complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol. 1991;79:335-336.
41. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988;55:185-192.
42. Dexter TM, Moore MA. in vitro duplication and "cure" of haematopoietic defects in genetically anaemic mice. Nature. 1977;269:412-414.
43. Stark R, Andre C, Thierry D, et al. The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias. Br J Haematol. 1993;83:560-566.
44. Alter BP, Knobloch ME, He L, et al. Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes. Blood. 1992;80:3000-3008.
45. Scoggins RB, Prescott KJ, Asher GH, et al. Dyskeratosis congenita with Fanconi-type anemia: investigations of immunologic and other defects. Clin Res. 1971;19:409.
46. Morrison JGL. Dyskeratosis congenita: two extremes. S Afr Med J. 1974;48:223-225.
47. Inoue S, Mekanik G, Mahallati M, Zuelzer WW. Dyskeraiosis congenita with pancytopenia. Another constitutional anemia. Am J Dis Child. 1973;126:389-396.
48. Schroeder TM, Hofbauer M. Letter: Dyskeratosis congenita. Zinsser-Cole Engman form with abnormal karyotype. Dermatologica. 1975;151:316-318.
49. Burgdorf W, Kurvink K, Cervenka J. Sister chromatid exchange in dyskeratosis congenita lymphocytes. J Med Genet. 1977;14:256-257.
50. Auerbach AD, Adler B, Ghaganti RSK. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics. 1981;67:128-135.
51. Pai GS, Yan Y, DeBauche DM, et al. Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts. Cytogenet Cell Genet. 1989;52:186-189.
52. Carter DM, Pan M, Gaynor A, et al. Psoralen-DNA crosslinking photoadducts in dyskeratosis congenita: delay in excision and promotion of sister chromatid exchange. J Invest Dermatol. 1979;73:97-101.
53. Kano Y, Fujiwara Y. Dyskeratosis congenita: survival, sister-chromatid exchange and repair following treatment with crosslinking agents. Mutat Res. 1982;103:327-332.
54. DeBauche DM, Pai GS, Stanley WS. Enhanced G2 chromatid radiosensitivity in dyskeratosis congenita fibroblasts. Am J Hum Genet. 1990;46:350-357.
55. Ning Y, Yongshan Y, Pai GS, Gross AJ. Heterozygote detection through bleomycin-induced G (2)-chromatid breakage in dyskeratosis congenita families. Cancer Genet Cytogenet. 1992;60:31-34.
56. Dokal I, Luzzatto L. Dyskeratosis congenita is a chromosomal instability disorder. Leuk Lymphoma. 1994;15:1-7.
57. Ogden OR, Lane DP, Chisholm DM. P53 expression in dyskeratosis congenita: a marker for oral premalignancy? J Clin Pathol. 1993;46:169-170.
58. Conter V, Johnson FL, Paolucci P, et al. Bone marrow transplantation for aplastic anemia associated with dyskeratosis congenita. Am J Pediatr Hematol Oncol. 1988;10:99-102.
59. Putterman C, Safadi R, Zlotogora J, et al. Treatment of the hematological manifestations of dyskeratosis congenita. Ann Hematol. 1993;66:209-212.
60. Oehler L, Reiter E, Friedl J, et al. Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report. Ann Hematol. 1994;69:325-327.
61. Pritchard SL, Junker AK. Positive response to granulocyte-colony-stimulating factor in dyskeratosh congenita before matched unrelated bone marrow transplantation. Am J Pediatr Hematol Oncol. 1994;16:173-176.
62. Dong F, Brynes RK, Tidow N, et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995;333:487-493.
63. Bargetzi MJ, Gluckman E, Tichelli A, et al. Recombinant human interleukin-3 in refractory severe aplastic anemia: a phase I/II trial. Br J Haematol. 1995;91:306-312.
64. Lemarchand-Vencncie F, Gluckman E, et al. Syndrome de Zinsser-Cole-Engman. Ann Dermatol Venerol. 1982;109:783-784.
65. Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anemia associated with dyskeratosis congenita. Br J Haematol. 1996;92:758-765.
66. Dokal I. Dyskeratosis congenita: an inherited bone marrow failure syndrome. Br J Haematol. 1996;92:775-779.
67. Forni GL, Melevendi C, Jappelli S, Rasore-Quartino A. Dyskeratosis congenita: unusual presenting features within a kindred. Pediatr Hematol Oncol. 1993;10:145-149.
68. Phillips RJ, Judge M, Webb D, Harper JI. Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation. Br J Dermatol. 1992;127: 278-280.
69. Goldman J. Peripheral blood stem cells for allografting. Blood. 1995;85: 1413-1415.